Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hyperalgesia D006930 42 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Ventricular Fibrillation D014693 16 associated lipids
Fever D005334 35 associated lipids
Anaphylaxis D000707 35 associated lipids
Pneumococcal Infections D011008 7 associated lipids
Thrombocytopenia D013921 15 associated lipids
Bronchial Spasm D001986 18 associated lipids
Shock, Septic D012772 11 associated lipids
Immune Complex Diseases D007105 9 associated lipids
Conjunctivitis D003231 7 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Rheumatic Diseases D012216 7 associated lipids
Death, Sudden D003645 12 associated lipids
Vitamin E Deficiency D014811 29 associated lipids
Cardiomegaly D006332 31 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Carbon Monoxide Poisoning D002249 9 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Davoine F et al. Interleukin-12 inhibits eosinophil degranulation and migration but does not promote eosinophil apoptosis. 2006 Int. Arch. Allergy Immunol. pmid:16735797
Woo HY et al. Mechanism for acute oral desensitization to antibiotics. 2006 Allergy pmid:16867049
Sallem W et al. Structure-activity relationships in platelet-activating factor. Part 14: synthesis and biological evaluation of piperazine derivatives with dual anti-PAF and anti-HIV-1 activity. 2006 Bioorg. Med. Chem. pmid:16908170
Lima RG et al. Interaction of macrophages with apoptotic cells enhances HIV Type 1 replication through PGE2, PAF, and vitronectin receptor. 2006 AIDS Res. Hum. Retroviruses pmid:16910832
Gora S et al. The proinflammatory mediator Platelet Activating Factor is an effective substrate for human group X secreted phospholipase A2. 2006 Biochim. Biophys. Acta pmid:16962371
Kassuya CA et al. Antiinflammatory and antiallodynic actions of the lignan niranthin isolated from Phyllanthus amarus. Evidence for interaction with platelet activating factor receptor. 2006 Eur. J. Pharmacol. pmid:16925995
Cauwels A et al. Anaphylactic shock depends on PI3K and eNOS-derived NO. 2006 J. Clin. Invest. pmid:16886062
Wolf P et al. Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis. 2006 Am. J. Pathol. pmid:16936256
Biancone L et al. Platelet-activating factor synthesis and response on pancreatic islet endothelial cells: relevance for islet transplantation. 2006 Transplantation pmid:16495796
McMeekin SR et al. E-selectin permits communication between PAF receptors and TRPC channels in human neutrophils. 2006 Blood pmid:16514053
Ramirez R et al. Angiotensin II effect on hydraulic permeability: interaction with endothelin-1, nitric oxide, and platelet activating factor. 2006 J. Surg. Res. pmid:16515797
He P et al. Leukocyte-platelet aggregate adhesion and vascular permeability in intact microvessels: role of activated endothelial cells. 2006 Am. J. Physiol. Heart Circ. Physiol. pmid:16517944
Okumura N et al. Pharmacokinetic analysis of platelet-activating factor in the tears of guinea pigs with allergic conjunctivitis. 2006 J Ocul Pharmacol Ther pmid:17076629
Keles GC et al. Levels of platelet activating factor in gingival crevice fluid following periodontal surgical therapy. 2006 J. Periodont. Res. pmid:17076775
Denizot Y et al. Platelet-activating factor and human meningiomas. 2006 Neuropathol. Appl. Neurobiol. pmid:17083481
Wang GD et al. Platelet-activating factor in the enteric nervous system of the guinea pig small intestine. 2006 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:17030900
Herman AG and Stockwell BR Enzyme annotation with chemical tools. 2006 Chem. Biol. pmid:17052604
Chiang KP et al. An enzyme that regulates ether lipid signaling pathways in cancer annotated by multidimensional profiling. 2006 Chem. Biol. pmid:17052608
Brown SL et al. Activation and regulation of platelet-activating factor receptor: role of G(i) and G(q) in receptor-mediated chemotactic, cytotoxic, and cross-regulatory signals. 2006 J. Immunol. pmid:16920964
Yang YP et al. Effect of increased hepatic platelet activating factor and its receptor portal hypertension in CCl4-induced liver cirrhosis. 2006 World J. Gastroenterol. pmid:16521183
Wang LJ et al. [Role of platelet activating factor in the injury of intestinal immuno-barrier function in young rats]. 2006 Zhongguo Dang Dai Er Ke Za Zhi pmid:16522243
Hong SH et al. Mitochondrial ligand inhibits store-operated calcium influx and COX-2 production in human microglia. 2006 J. Neurosci. Res. pmid:16547968
Tabarés-Seisdedos R et al. Variations in genes regulating neuronal migration predict reduced prefrontal cognition in schizophrenia and bipolar subjects from mediterranean Spain: a preliminary study. 2006 Neuroscience pmid:16549273
Heon Seo K et al. Platelet-activating factor induces up-regulation of antiapoptotic factors in a melanoma cell line through nuclear factor-kappaB activation. 2006 Cancer Res. pmid:16651419
Doi K et al. Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice. 2006 Am. J. Pathol. pmid:16651609
Coleus forskohlii. Monograph. 2006 Altern Med Rev pmid:16597194
Fernandes CJ and O'Donovan DJ Platelet transfusions in infants with necrotizing enterocolitis. 2006 Curr. Hematol. Rep. pmid:16537050
Maliba R et al. Angiopoietins-1 and -2 are both capable of mediating endothelial PAF synthesis: intracellular signalling pathways. 2006 Cell. Signal. pmid:16617006
Goldring WP and Pattenden G The phomactins. A novel group of terpenoid platelet activating factor antagonists related biogenetically to the taxanes. 2006 Acc. Chem. Res. pmid:16700534
Peng SY et al. Effect of ginkgolide B on the platelet-activating factor induced changes of chemotaxis and cytoskeleton of macrophages. 2006 Yao Xue Xue Bao pmid:16671547
Bate C et al. Platelet-activating factor antagonists protect amyloid-beta damaged neurons from microglia-mediated death. 2006 Neuropharmacology pmid:16678220
Sánchez FA et al. Functional significance of differential eNOS translocation. 2006 Am. J. Physiol. Heart Circ. Physiol. pmid:16679407
Mao YJ et al. [Effect of ginkgolide B on the function of rat aorta smooth cells and U937 cells stimulated by oxLDL]. 2006 Yao Xue Xue Bao pmid:16683525
Ko HM et al. Platelet-activating factor-induced NF-kappaB activation enhances VEGF expression through a decrease in p53 activity. 2006 FEBS Lett. pmid:16684540
Hermle T et al. Decreased cation channel activity and blunted channel-dependent eryptosis in neonatal erythrocytes. 2006 Am. J. Physiol., Cell Physiol. pmid:16723509
Fonseca FV et al. Characterization of a new platelet aggregating factor from crotoxin Crotalus durissus cascavella venom. 2006 Protein J. pmid:16729248
Wang C et al. Total synthesis of (+/-)-paeonilide. 2006 Org. Lett. pmid:16737293
Kaul DK et al. Peptides based on alphaV-binding domains of erythrocyte ICAM-4 inhibit sickle red cell-endothelial interactions and vaso-occlusion in the microcirculation. 2006 Am. J. Physiol., Cell Physiol. pmid:16738001
Kikuchi I et al. Eosinophil trans-basement membrane migration induced by interleukin-8 and neutrophils. 2006 Am. J. Respir. Cell Mol. Biol. pmid:16456187
Mauri P et al. LC-MS characterization of terpene lactones in plasma of experimental animals treated with Ginkgo biloba extracts Correlation with pharmacological activity. 2006 J Pharm Biomed Anal pmid:16343838
Kishimoto S et al. Chemotaxis of human peripheral blood eosinophils to 2-arachidonoylglycerol: comparison with other eosinophil chemoattractants. 2006 Int. Arch. Allergy Immunol. pmid:16772720
Cui S et al. Effects of platelet-activating factor, thromboxane A2 and leukotriene D4 on isolated perfused rat liver. 2006 Prostaglandins Other Lipid Mediat. pmid:16846785
Menezes-de-Lima O et al. Lipoxin A4 inhibits acute edema in mice: implications for the anti-edematogenic mechanism induced by aspirin. 2006 Prostaglandins Other Lipid Mediat. pmid:16939877
Shao P et al. [Research on relationship of syndrome type and parameters of hemorheology and platelet activation in patients with acute gout arthritis of dampness-heat blockage type and stasis-heat accumulate type]. 2006 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:17186728
Crespo A et al. [Effect of changes in airway pressure and the inspiratory volume on the fluid filtration rate and pulmonary artery pressure in isolated rabbit lungs perfused with blood and acellular solution]. 2006 Invest Clin pmid:17176901
Eckford PD and Sharom FJ P-glycoprotein (ABCB1) interacts directly with lipid-based anti-cancer drugs and platelet-activating factors. 2006 Biochem. Cell Biol. pmid:17215888
Subbanna PK and Tyagi MG PAF antagonism modifies neuroprotective action of histone deacetylase and calcineurin phosphatase inhibitors in mice. 2006 Indian J. Exp. Biol. pmid:17205708
Fang H et al. Anaphylactic reaction induced by Toxoplasma gondii-derived heat shock protein 70. 2006 Int. Immunol. pmid:16943259
Judge A et al. Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes. 2006 Mol. Ther. pmid:16275098
Desaulniers P et al. Characterization of an activation factor released from human neutrophils after stimulation by triclinic monosodium urate crystals. 2006 J. Rheumatol. pmid:16652423